What is a stock summary page? Click here for an overview.
Business Description
vTv Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US9183851057
Share Class Description:
VTVT: Class ADescription
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 217.43 | |||||
| Equity-to-Asset | 0.32 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -10.7 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -59 | |||||
| 3-Year EBITDA Growth Rate | 29.6 | |||||
| 3-Year EPS without NRI Growth Rate | 27.2 | |||||
| 3-Year FCF Growth Rate | 29.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -16.26 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.27 | |||||
| 9-Day RSI | 44.41 | |||||
| 14-Day RSI | 46.24 | |||||
| 3-1 Month Momentum % | 35.03 | |||||
| 6-1 Month Momentum % | 41.85 | |||||
| 12-1 Month Momentum % | -30.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.34 | |||||
| Quick Ratio | 7.34 | |||||
| Cash Ratio | 7.07 | |||||
| Days Sales Outstanding | 121.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16 | |||||
| Shareholder Yield % | -114.1 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -2377.58 | |||||
| Net Margin % | -1815.34 | |||||
| FCF Margin % | -2488.4 | |||||
| ROE % | -231.95 | |||||
| ROA % | -47.81 | |||||
| ROIC % | -2252.12 | |||||
| 3-Year ROIIC % | 21.23 | |||||
| ROC (Joel Greenblatt) % | -8655.16 | |||||
| ROCE % | -72 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 77.22 | |||||
| PB Ratio | 3.63 | |||||
| Price-to-Tangible-Book | 3.63 | |||||
| EV-to-EBIT | -0.35 | |||||
| EV-to-EBITDA | -0.35 | |||||
| EV-to-Revenue | 7.69 | |||||
| EV-to-Forward-Revenue | 29.28 | |||||
| EV-to-FCF | -0.3 | |||||
| Price-to-GF-Value | 1.25 | |||||
| Price-to-Net-Current-Asset-Value | 3.68 | |||||
| Price-to-Net-Cash | 4.15 | |||||
| Earnings Yield (Greenblatt) % | -285.71 | |||||
| FCF Yield % | -57.09 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VTVT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
vTv Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.017 | ||
| EPS (TTM) ($) | -3.41 | ||
| Beta | 0.51 | ||
| 3-Year Sharpe Ratio | 0.11 | ||
| 3-Year Sortino Ratio | 0.23 | ||
| Volatility % | 66.85 | ||
| 14-Day RSI | 46.24 | ||
| 14-Day ATR ($) | 2.12551 | ||
| 20-Day SMA ($) | 17.507275 | ||
| 12-1 Month Momentum % | -30.34 | ||
| 52-Week Range ($) | 12.1201 - 29.85 | ||
| Shares Outstanding (Mil) | 2.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
vTv Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
vTv Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
vTv Therapeutics Inc Frequently Asked Questions
What is vTv Therapeutics Inc(VTVT)'s stock price today?
The current price of VTVT is $16.97. The 52 week high of VTVT is $29.85 and 52 week low is $12.12.
When is next earnings date of vTv Therapeutics Inc(VTVT)?
The next earnings date of vTv Therapeutics Inc(VTVT) is 2025-05-09 Est..
Does vTv Therapeutics Inc(VTVT) pay dividends? If so, how much?
vTv Therapeutics Inc(VTVT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers